# OPUVIZ
> **BLA761350** · Biologics License Application · Sponsor: SAMSUNG BIOEPIS CO LTD · Approved 2024-05-20
## Drug
- **FDA Application Number:** BLA761350
- **Application type:** Biologics License Application
- **Brand name:** OPUVIZ
- **Generic name:** Aflibercept-Yszy
- **Active ingredients:** AFLIBERCEPT-YSZY
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SAMSUNG BIOEPIS CO LTD
- **First approval:** 2024-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761350)
---
*MORVS · CC0 1.0*